Jane Walker MBChB, MSc, PhD, MRCPsych

Dr.Walker research focuses on improving the quality of life of people with chronic and life-limiting diseases. I develop new treatments for patients with depression and anxiety and evaluate these in rigorous clinical trials.She is currently working on studies of treatments for people with cancer and depression and for patients with complications of diabetes.

She have expertise in the design and conduct of clinical trials, particularly those of psychological and multi-component interventions.She work clinically at Sir Michael Sobell House Hospice.

Her publications are as follows:
Updates in Psychosomatic Medicine: 2014. Freudenreich O. et al, (2015), Psychosomatics, 56, 445 - 459.
Implementing collaborative care programs for psychiatric disorders in medical settings: a practical guide. Beach SR. et al, (2015), Gen Hosp Psychiatry
Selecting, training and supervising nurses to treat depression in the medically ill: experience and recommendations from the SMaRT oncology collaborative care trials. Wanat M. et al, (2015), Gen Hosp Psychiatry.
Updates in Psychosomatic Medicine: 2014 Freudenreich O. et al, (2015), Psychosomatics, 56, 445 - 459.
Treatment of depression in people with lung cancer: a systematic review. Walker J. et al, (2013), Lung Cancer, 79, 46 - 53.
Prevalence of depression in adults with cancer: A systematic review Walker J. et al, (2012), Annals of Oncology.
Guided self-help for functional (psychogenic) symptoms: A randomized controlled efficacy trial Sharpe M. et al, (2011), Neurol., 77, 564 - 572.
Better off dead: suicidal thoughts in cancer patients Walker J. et al, (2008), j.clin.oncol., 26, 4725 - 4730.